Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Gross Margin (2016 - 2025)

Firefly Neuroscience has reported Gross Margin over the past 15 years, most recently at 44.17% for Q4 2025.

  • Quarterly results put Gross Margin at 44.17% for Q4 2025, down 5583.0% from a year ago — trailing twelve months through Dec 2025 was 38.27% (down 69808.0% YoY), and the annual figure for FY2025 was 56.48%, down 4352.0%.
  • Gross Margin for Q4 2025 was 44.17% at Firefly Neuroscience, up from 37.63% in the prior quarter.
  • Over the last five years, Gross Margin for AIFF hit a ceiling of 5827.15% in Q1 2024 and a floor of 383.72% in Q1 2025.
  • Median Gross Margin over the past 5 years was 32.02% (2022), compared with a mean of 466.33%.
  • Biggest five-year swings in Gross Margin: surged 579674bps in 2024 and later crashed -621087bps in 2025.
  • Firefly Neuroscience's Gross Margin stood at 22.76% in 2021, then rose by 17bps to 26.59% in 2022, then crashed by -573bps to 125.82% in 2023, then soared by 179bps to 100.0% in 2024, then tumbled by -56bps to 44.17% in 2025.
  • The last three reported values for Gross Margin were 44.17% (Q4 2025), 37.63% (Q3 2025), and 91.64% (Q2 2025) per Business Quant data.